The Upper Gastrointestinal (UGI) multidisciplinary Multidisciplinary team (MDT) makes critical treatment decisions in every oesophageal cancer patient’s journey (e.g., neoadjuvant therapies, expedited surgery or palliation). This has a profound impact on survival and quality of life. Recent studies have highlighted that rising caseloads and time pressures can lead to inconsistent and suboptimal decisions. Machine learning (ML) offers the potential to standardise and deliver data-driven decisions. We will mirror the decision-making process by incorporating human-selected critical variables and work with practitioners to assess regulatory and practical challenges (as human-AI partnerships) to ensure that the solution is trustworthy for routine clinical use.

Purpose:

1. We set out to improve physical and mental well-being by focusing on improvements in the consistency of cancer care decision-making for all Oesophageal adenocarcinoma (OAC) patients; treatment decisions confer significant implications for patient and relatives’ quality of life (mental and physical).

2. We seek to ensure that pivotal treatment decisions are data-driven and consistent so that all patients in equivalent circumstances are treated fairly and thereby promote justice and health equality.

3. Finally, an explainable AI approach provides a unique opportunity to uncover subconscious biases within the way we currently make cancer treatment decisions. This in turn allows us to challenge preconceived biases or subsequent inequality that may result and allows for the creation of an inclusive, fair and just world. Once implemented, our solution will seek to automate and streamline workflows with a direct impact on the efficiency of the OAC MDT, and in a wider sense, the health economy.

To do this we will analyse the UGI cancer MDT at UHS (a busy tertiary centre) to collect decision-making factors. This includes clinical and patient factors (age, comorbidities, cTNM, performance status) and human factors (e.g., types of MDT members present, MDT lead). Using retrospective data we will develop a prototype mirror ML model which integrates clinical, radiological, histological, and social variables to predict outcomes. We will utilise our prototype mirror ML model to conduct semi-structured interviews with physicians (chosen from AUGIS/UAOS/BSG/UKIOG) and present decision scenarios to discuss AI acceptability. This will show how users engage with our model and reveal crucial technical, cultural, psychological, and socio-economic elements affecting human-AI teaming.

Find out more 

You can read more about this project through two blogs:

1.Unveiling the importance of Age in Oesophageal Cancer Treatment Decisions: An Interpretable Machine Learning Approach

2.Enhancing Decision Support in Oesophageal Cancer Treatment

Our Team

Meet the Team

Dr Ganesh Vigneswaran

NIHR Clinical Lecturer in Interventional Radiology, University of Southampton

Lead Contact

Professor Tim Underwood

Professor of Gastrointestinal Surgery, University of Southampton

Co-Investigator

Professor Sarvapali (Gopal) Ramchurn

Professor of Artificial Intelligence, Director of TAs Hub, University of Southampton

Advisor

Dr Zoë Walters

Associate Professor in Translational Epigenomics, University of Southampton

Co-Investigator

Dr Mohammad Naiseh

Lecturer of AI and Data Science, University of Bournemouth

Co-Investigator

Dr Indu Bodala

Lecturer in Electronics and Computer Science, University of Southampton

Co-Investigator

Dr Tayyaba Azim

Research fellow at Agents, Interaction and Control (AIC), University of Southampton

Co-Investigator

Professor Michael Boniface

Professorial Fellow in Information Technology, University of Southampton

Advisor

Dr Liam Ingram

Consultant GI Radiologist, University Hospital Southampton

Advisor

Professor Elvira Perez

Professor of Mental Health and Digital Technology, University of Nottingham

Advisor

Our Project Partners